Evotec Rises on Harvard Diabetes Pact Discovery: Hamburg Mover

Evotec AG rose for a third day as researchers in its CureBeta pact said they discovered a hormone that holds promise as a novel diabetes treatment.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.